The Role of Biomarkers of Inflammation in Cardiovascular Disease is the third of 12 programs in AACC’s “High-Value Tests for High-Impact Diseases” webinar series. The webinar features Paul Ridker, MD, who will examine the uses and limitations of inflammatory biomarkers such as hsCRP and Lp-PLA2, and review current evidence regarding the effectiveness of statin therapy and the role markers of inflammation can play in reducing cardiovascular disease risk.